Drug Price Regulation, B.C. Reg. 344/2012
Section 10
Maximum payment for high cost drugs
Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 10 · last amended March 1, 2026 · read from BC Laws on November 17, 2026
The text
(1) The maximum amount the minister may pay for a high cost drug that is not subject to the LCA program is the sum of the manufacturer's list price for the drug and 5% of that price.
(2) The maximum amount the minister may pay for a high cost drug that is subject to the LCA program is the lesser of
(a) the amount determined under subsection (1), as if the high cost drug were not subject to the LCA program, and
(b) the applicable amount from among the following:
(i) if, in the LCA category to which the high cost drug belongs, there are only high cost drugs and none are provisional drugs, the sum of the maximum accepted list price for the LCA category to which the drug belongs and 5% of that price;
(ii) if, in the LCA category to which the high cost drug belongs, there are one or more drugs that are not high cost drugs but there are no provisional drugs, the sum of the maximum accepted list price for the LCA category to which the drug belongs and 8% of that price;
(iii) if, in the LCA category to which the high cost drug belongs, there are one or more provisional drugs, the maximum amount the minister may pay for a drug under section 11 (4) [prices for other drugs].
Read the Drug Price Regulation on BC Laws ↗
Made under Pharmaceutical Services Act, SBC 2012, c. 22.